BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16101666)

  • 1. Developments in the inhibition of gastric acid secretion.
    Mössner J; Caca K
    Eur J Clin Invest; 2005 Aug; 35(8):469-75. PubMed ID: 16101666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
    Andersson K; Carlsson E
    Pharmacol Ther; 2005 Dec; 108(3):294-307. PubMed ID: 16000224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological targets in gastro-oesophageal reflux disease.
    Piche T; Galmiche JP
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):333-41. PubMed ID: 16364047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
    Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
    J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological basis of omeprazole therapy.
    Sachs G; Wallmark B
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():7-18. PubMed ID: 2562365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving on PPI-based therapy of GORD.
    Sachs G
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S35-41. PubMed ID: 11430507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid secretion and the H,K ATPase of stomach.
    Prinz C; Kajimura M; Scott D; Helander H; Shin J; Besancon M; Bamberg K; Hersey S; Sachs G
    Yale J Biol Med; 1992; 65(6):577-96. PubMed ID: 1341065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of gastric acid secretion in health and disease.
    Schubert ML; Peura DA
    Gastroenterology; 2008 Jun; 134(7):1842-60. PubMed ID: 18474247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular mechanism of gastric acid secretion and mode of action of inhibiting drugs].
    Lewin M
    Rev Med Suisse Romande; 1995 Oct; 115(10):767-72. PubMed ID: 7501928
    [No Abstract]   [Full Text] [Related]  

  • 11. Why is the high grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective.
    Orlando RC
    Am J Gastroenterol; 1996 Sep; 91(9):1692-6. PubMed ID: 8792683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
    Hori Y; Matsukawa J; Takeuchi T; Nishida H; Kajino M; Inatomi N
    J Pharmacol Exp Ther; 2011 Jun; 337(3):797-804. PubMed ID: 21411494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroesophageal reflux disease (GERD): is there more to the story?
    Vesper BJ; Altman KW; Elseth KM; Haines GK; Pavlova SI; Tao L; Tarjan G; Radosevich JA
    ChemMedChem; 2008 Apr; 3(4):552-9. PubMed ID: 18076011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell physiology and pharmacology of gastric acid secretion.
    Lewin MJ
    Therapie; 1992; 47(2):93-6. PubMed ID: 1357771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century.
    Konturek SJ; Konturek PC; Brzozowski T; Konturek JW; Pawlik WW
    J Physiol Pharmacol; 2005 Dec; 56(4):507-30. PubMed ID: 16391411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of acid-related disorders in the United States.
    Brown M; Yang RD
    Manag Care; 2001 Oct; 10(10 Suppl):7-10. PubMed ID: 11729446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.
    Shin JM; Cho YM; Sachs G
    J Am Chem Soc; 2004 Jun; 126(25):7800-11. PubMed ID: 15212527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: the clinical pharmacology of proton pump inhibitors.
    Sachs G; Shin JM; Howden CW
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():2-8. PubMed ID: 16700898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approaches to the pharmacological blockade of gastric acid secretion.
    Parsons ME; Keeling DJ
    Expert Opin Investig Drugs; 2005 Apr; 14(4):411-21. PubMed ID: 15882117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The calcium-sensing receptor acts as a modulator of gastric acid secretion in freshly isolated human gastric glands.
    Dufner MM; Kirchhoff P; Remy C; Hafner P; Müller MK; Cheng SX; Tang LQ; Hebert SC; Geibel JP; Wagner CA
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1084-90. PubMed ID: 16109841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.